SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Kyoung Woon Kim, Byung Ha Chung, Bo-Mi Kim, Mi-La Cho, Chul Woo Yang, The effect of mammalian target of rapamycin inhibition on T helper type 17 and regulatory T cell differentiation in vitro and in vivo in kidney transplant recipients, Immunology, 2015, 144, 1
  2. 2
    Peter Urbanellis, Wendy Shyu, Ramzi Khattar, Jihong Wang, Anna Zakharova, Wei He, Hassan Sadozai, Achiya Z. Amir, Itay Shalev, M. James Phillips, Oyedele Adeyi, Heather Ross, David Grant, Gary A. Levy, Andrzej Chruscinski, The regulatory T cell effector molecule fibrinogen-like protein 2 is necessary for the development of rapamycin-induced tolerance to fully MHC-mismatched murine cardiac allografts, Immunology, 2015, 144, 1
  3. 3
    M Corti, ME Elder, DJ Falk, L Lawson, BK Smith, S Nayak, TJ Conlon, N Clément, K Erger, E Lavassani, MM Green, PA Doerfler, RW Herzog, BJ Byrne, B-cell depletion is protective against anti-AAV capsid immune response: a human subject case study, Molecular Therapy — Methods & Clinical Development, 2014, 1, 14033

    CrossRef

  4. 4
    Kristen N. Pollizzi, Jonathan D. Powell, Integrating canonical and metabolic signalling programmes in the regulation of T cell responses, Nature Reviews Immunology, 2014, 14, 7, 435

    CrossRef

  5. 5
    Giovanni Stallone, Paola Pontrelli, Barbara Infante, Margherita Gigante, Giuseppe S Netti, Elena Ranieri, Giuseppe Grandaliano, Loreto Gesualdo, Rapamycin induces ILT3highILT4high dendritic cells promoting a new immunoregulatory pathway, Kidney International, 2014, 85, 4, 888

    CrossRef

  6. 6
    Goran B. Klintmalm, Björn Nashan, The Role of mTOR Inhibitors in Liver Transplantation: Reviewing the Evidence, Journal of Transplantation, 2014, 2014, 1

    CrossRef

  7. 7
    Melissa E. Elder, Sushrusha Nayak, Shelley W. Collins, Lee Ann Lawson, Jeffry S. Kelley, Roland W. Herzog, Renee F. Modica, Judy Lew, Robert M. Lawrence, Barry J. Byrne, B-Cell Depletion and Immunomodulation before Initiation of Enzyme Replacement Therapy Blocks the Immune Response to Acid Alpha-Glucosidase in Infantile-Onset Pompe Disease, The Journal of Pediatrics, 2013, 163, 3, 847

    CrossRef

  8. 8
    Maria-Carlota Londoño, Antoni Rimola, John O’Grady, Alberto Sanchez-Fueyo, Immunosuppression minimization vs. complete drug withdrawal in liver transplantation, Journal of Hepatology, 2013, 59, 4, 872

    CrossRef

  9. 9
    Josh Levitsky, Immunosuppression withdrawal following liver transplantation: The older, the wiser… but maybe too late, Hepatology, 2013, 58, 5
  10. 10
    Xiao-Jun Wang, Dennis Leveson-Gower, Karolina Golab, Ling-Jia Wang, Natalia Marek-Trzonkowska, Adam Krzystyniak, Anna Wardowska, J Michael Millis, Piotr Trzonkowski, Piotr Witkowski, Influence of pharmacological immunomodulatory agents on CD4+CD25highFoxP3+ T regulatory cells in humans, International Immunopharmacology, 2013, 16, 3, 364

    CrossRef

  11. 11
    Josh Levitsky, Joshua Miller, Xuemei Huang, Dhivya Chandrasekaran, Li Chen, James M. Mathew, Inhibitory Effects of Belatacept on Allospecific Regulatory T-Cell Generation in Humans, Transplantation Journal, 2013, 96, 8, 689

    CrossRef

  12. 12
    Goran Klintmalm, Cliona O'Farrelly, Taking the rap: Multiple effects of blocking mammalian target of rapamycin, Hepatology, 2013, 57, 1
  13. 13
    Katelin N. Townsend, Luke R. K. Hughson, Katrin Schlie, Vincent I. Poon, Ashley Westerback, Julian J. Lum, Autophagy inhibition in cancer therapy: metabolic considerations for antitumor immunity, Immunological Reviews, 2012, 249, 1